Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-Apr-24 5:44 PM View:  | Fairmount Funds Management ... Director | Apogee Therapeutics, Inc. (APGE) | 28-Mar-24 | Acquisition (other) | 55,913 | -- | -- | 3% 2.15M to 2.21M | |
| 01-Apr-24 5:44 PM View: | Fairmount Funds Management ... Director | Apogee Therapeutics, Inc. (APGE) | 28-Mar-24 | Disposition (other) | 55,913 | -- | -- | (3%) 2.21M to 2.15M | |
| 31-Jan-24 4:31 PM View: | Fairmount Funds Management ... Director | Apogee Therapeutics, Inc. (APGE) | 29-Jan-24 | Acquisition (other) | 102,332 | -- | -- | 11% 892.53K to 994.86K | |
| 31-Jan-24 4:31 PM View: | Fairmount Funds Management ... Director | Apogee Therapeutics, Inc. (APGE) | 29-Jan-24 | Disposition (other) | 892,529 | -- | -- | (90%) 994.86K to 102.33K | |
| 17-Jul-23 8:00 PM View: | Shah Nimish P Director | Apogee Therapeutics, Inc. (APGE) | 13-Jul-23 | Purchase | 1,750,000 | $17.00 | $29,750,000.00 | 100% 0 to 1.75M | |
| 17-Jul-23 8:00 PM View: | Fairmount Funds Management ... Director | Apogee Therapeutics, Inc. (APGE) | 13-Jul-23 | Purchase | 2,941,180 | $17.00 | $50,000,000.00 | 100% 0 to 2.94M |
